The Cancer Aetiology and Prevention Laboratory covers three broad research areas: causes and management of pancreatic cancer, the role of vitamin D in human health, and causes and management of non-melanoma skin cancer. A/Prof Neale and her team have published a series of papers describing inequity in management of pancreatic cancer according to sociodemographic factors, and the very high supportive care needs of patients. She is now investigating ways to deliver better supportive care to these vulnerable patients.
A/Prof Neale is the principal investigator of the D-Health Trial, the second-largest trial of high-dose vitamin D supplementation in the world. Over 21,000 adults were enrolled and randomised to vitamin D or placebo, taken monthly for 5 years. The intervention phase will continue until May 2020. This project will generate data to inform policy makers and clinicians about the benefits or otherwise of population-wide vitamin D supplementation and will also provide a platform for the training of multiple students.
Associate Professor Rachel Neale’s complete list of publications can be viewed at her PubMed bibliography page.
- Can common medications be repurposed to reduce risk of or mortality from pancreatic cancer
- The D-Health Trial
If you wish to apply for QIMR Berghofer's student program,
click here for more information.